Key result
Two human iPSC lines carrying a heterozygous MYBPC3 mutation were successfully generated from an HCM patient and his daughter, demonstrating normal karyotype and pluripotency.
Why the study?
Hypertrophic cardiomyopathy is an inherited heart disease often caused by sarcomeric gene mutations, predominantly in MYBPC3, requiring cellular models to study its molecular basis and screen drugs.
The generation of these MYBPC3 mutation-carrying iPSC lines provides a valuable in vitro model for studying the molecular mechanisms of hypertrophic cardiomyopathy and for drug screening.
Answers are grounded in this paper and cite their sources.
iPSC lines enable in vitro HCM modeling and screening; leaves open clinical translation pending functional validation.
Hypertrophic cardiomyopathy (HCM) is an inherited heart disease that can cause sudden cardiac death and heart failure. HCM often arises from mutations in sarcomeric genes, among which the MYBPC3 is the most frequently mutated. Here we generated two human induced pluripotent stem cell (iPSC) lines from a HCM patient who has a familial history of HCM and his daughter who carries the pathogenic non-coding mutation. All lines show the typical morphology of pluripotent cells, a high expression of pluripotency markers, normal karyotype, and in vitro capacity to differentiate into all three germ layers. These lines provide a valuable resource for studying the molecular basis of HCM and drug screening for HCM.
No takes yet. Share an insight, caveat, or question.
Liu et al. (2021) studied Hypertrophic cardiomyopathy (n=2). Generation of induced pluripotent stem cell (iPSC) lines was evaluated on Cell line morphology, pluripotency marker expression, karyotype, and in vitro differentiation capacity. Two human iPSC lines carrying a heterozygous MYBPC3 mutation were successfully generated from an HCM patient and his daughter, demonstrating normal karyotype and pluripotency.
Synapse has enriched 10 related papers. Consider them for comparative context: